Community Models for Hypertension and Diabetes Care for Refugees
NCT ID: NCT04229667
Last Updated: 2021-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
600 participants
OBSERVATIONAL
2020-01-31
2020-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Community- and mHealth-Based Integrated Management of Diabetes in Primary Healthcare in Rwanda
NCT03376607
Community-based CBT and T2D in Latino Population
NCT05222373
Diabetes Prevention in Prediabetic Patients
NCT01659697
vDPP Facilitated With Community Care Coordination
NCT04195477
Improving Diabetes Care Collaboratively in the Community
NCT00359996
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Since the arrival of refugees from Syria in 2012, the International Rescue Committee (IRC) has provided primary health care, mobile outreach, and community-based empowerment programs for those in need in the northern governorates of Mafraq and Ramtha. The IRC runs health clinics, mobile medical teams, and community health volunteer (CHV) networks to provide care for refugees and Jordanians living in poverty.
This stepped-wedge observational study will follow the implementation of an improved CHV program which focuses on the monitoring of 'high-needs' patients in their households for complications, severe disease, and to avoid interruptions to treatment adherence. The stepped-wedge design will be undertaken to benefit from the phased rollout of the improved CHV intervention over a year-long period. The intervention will be scaled to 20 CHV-neighborhoods across Mafraq and Ramtha.
Primary objectives:
* To evaluate the impact of an improved CHV program that targets high-needs hypertension and diabetes patients on:
* Compliance with routine clinic visits.
* Adherence to medications (self-reported).
* Adherence behaviours (self-reported).
* Disease control outcomes (blood pressure control for hypertension patients; blood sugar control for diabetes patients).
Secondary objectives:
* To document the operations of the improved CHV program in terms of key operational indicators and health indicators.
* To produce lessons learned to improve the CHV program.
Study outcomes:
* Evidence of the effectiveness of the improved CHV strategy on clinic visit compliance, adherence, and patient outcomes.
* Improved guidance for developing and implementing an integrated model of primary care and community health worker networks in crises.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Improved Community Health Volunteer (CHV) program
Multi-modal intervention targeting intensive household monitoring of "high-needs" patients using monthly visits to measure blood pressure and blood sugar, adherence to treatments and compliance with clinics visits, and motivational interviewing to facilitate behavior change and psychosocial support.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
1. Poor adherence, defined as:
\- Missed ≥2 appointments in the past six months AND/OR;
2. Poor disease control:
Hypertension: Blood pressure \>160/90 (EHS/ESC Grade II/III) with or without therapy, on their last measurement in clinic AND/OR; Evidence of hypertensive end organ damage including ischemic heart disease, left ventricular hypertrophy on ECG, eGFR \< 60, hypertensive retinopathy, heart failure, myocardial infarction AND/OR; Type II diabetes: HbA1C is \>8.5% OR random blood glucose \>200 mg/dL with or without insulin/pill therapy AND/OR; Patient has comorbidity and/or evidence of diabetic end organ damage, including ischemic heart disease, left ventricular hypertrophy on ECG, eGFR \< 60, retinopathy, heart failure, myocardial infarction, poorly healing wounds (e.g., diabetic foot), amputation, blindness and eye problems.
3. Comorbid diabetes and hypertension:
4. Disabled (house-bound)
5. Type I diabetes (insulin-dependent): all adult cases of insulin-dependent diabetes (likely type I diabetes), due to the nature of treatment interruption which causes rapid decompensations.
Exclusion Criteria
* Hospitalization for the majority of the study period
* Patients who leave the study neighborhood or repatriate to Syria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Southern California
OTHER
Jordan University of Science and Technology
OTHER
International Rescue Committee
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
International Rescue Committee
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H 1.00.020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.